This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Angela Yen, MD
Department of Dermatology 4.112 McCullough Bldg Galveston, TX 77555-0783

Sharon S. Raimer, MD
Galveston, Tex

Arch Dermatol. 1995;131(2):227.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

We read with interest the article by Arbiser et al in the June 1994 issue of the ARCHIVES.¹ They described two patients with erythrodermic psoriasis in whom rapid improvement was seen after initiation of occlusive therapy with topical class 1 steroids. Because of potential side effects from widespread use of class 1 steroids under occlusion and the expense of such treatment, we have reservations about the use of very potent steroids under occlusion as initial therapy.

In both cases reported, a coexisting infection existed that was not treated with antibiotics until the patient was hospitalized. Reported precipitating factors of erythrodermic psoriasis include preceding or coexisting infections, and an untreated coexisting infection can prevent response to treatment. In our experience, occlusive therapy with a mixture of eucerin and 0.1% triamcinolone cream for 15 to 20 minutes two to three times a day produces clearance of erythrodermic psoriasis in 3 days, . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?